Axonyx to Relocate Its New York Office on March 1, 2003.Business Editors NEW YORK--(BUSINESS WIRE)--Feb. 3, 2003 Axonyx Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : AXYX) today announced that it is relocating its New York New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of office on March 1, 2003. The new address and new contact numbers will be: -0- Axonyx Inc. 500 Seventh Avenue 10th floor New York, NY, 10018 Telephone: 212. 645.7704 Fax: 212.989.1745 Website: www.axonyx.com About Axonyx Axonyx Inc. is a U.S.-based biopharmaceutical company engaged in the acquisition and development of proprietary pharmaceutical compounds and new technologies useful in the diagnosis and treatment of Alzheimer's disease Alzheimer's disease (ăls`hī'mərz, ôls–), degenerative disease of nerve cells in the cerebral cortex that leads to atrophy of the brain and senile dementia. , human memory disorders and prion-based illnesses such as Mad Cow Disease mad cow disease: see prion. mad cow disease or bovine spongiform encephalopathy (BSE) Fatal neurodegenerative disease of cattle. Symptoms include behavioral changes (e.g. . |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion